KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Common Equity (2016 - 2025)

Ionis Pharmaceuticals has reported Common Equity over the past 17 years, most recently at $489.1 million for Q4 2025.

  • Quarterly results put Common Equity at $489.1 million for Q4 2025, down 16.87% from a year ago — trailing twelve months through Dec 2025 was $489.1 million (down 16.87% YoY), and the annual figure for FY2025 was $489.1 million, down 16.87%.
  • Common Equity for Q4 2025 was $489.1 million at Ionis Pharmaceuticals, down from $618.0 million in the prior quarter.
  • Over the last five years, Common Equity for IONS hit a ceiling of $771.7 million in Q4 2021 and a floor of $263.7 million in Q2 2024.
  • Median Common Equity over the past 5 years was $577.8 million (2021), compared with a mean of $535.5 million.
  • Biggest five-year swings in Common Equity: plummeted 65.11% in 2021 and later surged 139.56% in 2025.
  • Ionis Pharmaceuticals' Common Equity stood at $771.7 million in 2021, then decreased by 25.77% to $572.9 million in 2022, then tumbled by 32.5% to $386.7 million in 2023, then skyrocketed by 52.15% to $588.4 million in 2024, then dropped by 16.87% to $489.1 million in 2025.
  • The last three reported values for Common Equity were $489.1 million (Q4 2025), $618.0 million (Q3 2025), and $631.7 million (Q2 2025) per Business Quant data.